SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-005235
Filing Date
2018-01-24
Accepted
2018-01-24 18:52:44
Documents
2
Period of Report
2018-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3988
2 EX-24 DOCUMENT attachment1.htm EX-24 3414
  Complete submission text file 0001209191-18-005235.txt   8825
Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
Whitcup Scott M (Reporting) CIK: 0001298941 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 18546332

Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations